Research

LIke ThisLIke ThisLIke This

Mihail Samnaliev, PhD

Man no face
Hospital Title:
Health Economist
Academic Title:
Assistant Professor, Harvard Medical School
Research Focus Area:
cost effectivenessEconomic ModelingEconometricsHealth Economics Statistics
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*

Research Overview

Economic evaluations of clinical interventions, health care policies and programs Experience with cost, cost effectiveness and cost-of-illness analysis Statistical analysis (SAS, STATA) & economic modelling (TreeAge, Excel) Collection and analysis of patient-reported outcomes (HRQL and non-health care costs) Consult research investigators and clinicians from study concept to publication of results; mentor junior investigators

About the Researcher

Mihail Samnaliev has 15 years of experience with economic evaluations, health economics and outcomes research, and statistical analysis. He consults research investigators and clinicians from study concept to publication of results. Over the past 15 years he has been the lead economist for a number of studies evaluating clinical interventions, health care policies and programs and has supervised or conducted the statistical analyses of numerous observational studies. He is an Assistant Professor at Harvard Medical School.

Publications

Publications powered by Harvard Catalyst Profiles
  1. Weir S, Samnaliev M, Kuo TC, Ni Choitir C, Tierney TS, Cumming D, Bruce J, Manca A, Taylor RS, Eldabe S. The incidence and healthcare costs of persistent postoperative pain following lumbar spine surgery in the UK: a cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). BMJ Open. 2017 Sep 11; 7(9):e017585.
  2. Rathod RH, Jurgen B, Hamershock RA, Friedman KG, Marshall AC, Samnaliev M, Graham DA, Jenkins K, Lock JE, Powell AJ. Impact of standardized clinical assessment and management plans on resource utilization and costs in children after the arterial switch operation. Congenit Heart Dis. 2017 Jun 28.
  3. Phipatanakul W, Koutrakis P, Coull BA, Kang CM, Wolfson JM, Ferguson ST, Petty CR, Samnaliev M, Cunningham A, Sheehan WJ, Gaffin JM, Baxi SN, Lai PS, Permaul P, Liang L, Thorne PS, Adamkiewicz G, Brennan KJ, Baccarelli AA, Gold DR. The School Inner-City Asthma Intervention Study: Design, rationale, methods, and lessons learned. Contemp Clin Trials. 2017 Sep; 60:14-23.
  4. Gordon AR, Krieger N, Okechukwu CA, Haneuse S, Samnaliev M, Charlton BM, Austin SB. Decrements in health-related quality of life associated with gender nonconformity among U.S. adolescents and young adults. Qual Life Res. 2017 Aug; 26(8):2129-2138.
  5. Devji TF, Madenci AL, Carpino E, Leahy IC, Samnaliev M, Dearden JL, Weil BR, Weldon CB, Cravero J. Safety and cost-effectiveness of port removal outside of the operating room among pediatric patients. J Pediatr Surg. 2016 Nov; 51(11):1891-1895.
  6. Nathan M, Gauvreau K, Samnaliev M, Ozonoff A, Jenkins K, Bergersen L, Connor J, Pigula FA, Colan SD, Mayer JE, Del Nido PJ. Technical Performance Score Predicts Resource Utilization in Congenital Cardiac Procedures. J Am Coll Cardiol. 2016 Jun 07; 67(22):2696-8.
  7. Monuteaux MC, Bourgeois FT, Mannix R, Samnaliev M, Stack AM. Variation and Trends in Charges for Pediatric Care in Massachusetts Emergency Departments, 2000-2011. Acad Emerg Med. 2015 Oct; 22(10):1164-71.
  8. Nigrovic LE, Stack AM, Mannix RC, Lyons TW, Samnaliev M, Bachur RG, Proctor MR. Quality Improvement Effort to Reduce Cranial CTs for Children With Minor Blunt Head Trauma. Pediatrics. 2015 Jul; 136(1):e227-33.
  9. Archer NM, Samnaliev M, Grace R, Brugnara C. The utility of the DDAVP challenge test in children with low von Willebrand factor. Br J Haematol. 2015 Sep; 170(6):884-6.
  10. Zachariah JP, Samnaliev M. Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model. J Med Econ. 2015 Jun; 18(6):410-9.
  11. Show all
  12. Bairdain S, Samnaliev M. Cost-effectiveness of Adolescent Bariatric Surgery. Cureus. 2015 Feb; 7(2):e248.
  13. Baxter JD, Clark RE, Samnaliev M, Aweh G, O'Connell E. Adherence to Buprenorphine Treatment Guidelines in a Medicaid Program. Subst Abus. 2015; 36(2):174-82.
  14. Samnaliev M, Noh HL, Sonneville KR, Austin SB. The economic burden of eating disorders and related mental health comorbidities: An exploratory analysis using the U.S. Medical Expenditures Panel Survey. Prev Med Rep. 2015; 2:32-4.
  15. Samnaliev M. The Impact of Discrimination, Victimization and Social Standing on Health-Related Quality of Life. Value Health. 2014 Nov; 17(7):A331.
  16. Samnaliev M, Wijeratne R, Kwon EG, Ohiomoba H, Ng MW. Cost-effectiveness of a disease management program for early childhood caries. J Public Health Dent. 2015; 75(1):24-33.
  17. Akenroye AT, Baskin MN, Samnaliev M, Stack AM. Impact of a bronchiolitis guideline on ED resource use and cost: a segmented time-series analysis. Pediatrics. 2014 Jan; 133(1):e227-34.
  18. Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM. Economic evaluation of cell salvage in pediatric surgery. Paediatr Anaesth. 2013 Nov; 23(11):1027-34.
  19. Samnaliev M, Lightdale JR. On the cost-effectiveness of the use of probiotics in inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011 Nov; 53(5):473.
  20. Clark RE, Samnaliev M, Baxter JD, Leung GY. The evidence doesn't justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine. Health Aff (Millwood). 2011 Aug; 30(8):1425-33.
  21. Baxter JD, Clark RE, Samnaliev M, Leung GY, Hashemi L. Factors associated with Medicaid patients' access to buprenorphine treatment. J Subst Abuse Treat. 2011 Jul; 41(1):88-96.
  22. Samnaliev M, McGovern MP, Clark RE. Racial/ethnic disparities in mental health treatment in six Medicaid programs. J Health Care Poor Underserved. 2009 Feb; 20(1):165-76.
  23. Clark RE, Samnaliev M, McGovern MP. Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders. Psychiatr Serv. 2009 Jan; 60(1):35-42.
  24. Baxter JD, Samnaliev M, Clark RE. The quality of asthma care among adults with substance-related disorders and adults with mental illness. Psychiatr Serv. 2009 Jan; 60(1):43-9.
  25. Samnaliev M, Baxter JD, Clark RE. Comparative evaluation of two asthma care quality measures among Medicaid beneficiaries. Chest. 2009 May; 135(5):1193-1196.
  26. Baxter JD, Samnaliev M, Clark RE. Patterns of health care utilization for asthma treatment in adults with substance use disorders. J Addict Med. 2008 Jun; 2(2):79-84.
  27. Clark RE, Samnaliev M, McGovern MP. Treatment for co-occurring mental and substance use disorders in five state Medicaid programs. Psychiatr Serv. 2007 Jul; 58(7):942-8.
  28. McGovern MP, Clark RE, Samnaliev M. Co-occurring psychiatric and substance use disorders: a multistate feasibility study of the quadrant model. Psychiatr Serv. 2007 Jul; 58(7):949-54.
  29. Clark RE, Samnaliev M. Psychosocial treatment in the 21st century. Int J Law Psychiatry. 2005 Sep-Oct; 28(5):532-44.
LIke ThisLIke ThisLIke This
Close